Biosynthesis of fattiviracin FV-8, an antiviral agent

Bioscience, Biotechnology and Biochemistry

Volumn 65, Issue 4, 2001, Pages 861-864

  Habib, EL Sayed E ^a   Yokomizo, Kazumi ^a   Suzuki, Keitarou ^a   Uyeda, Masaru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antiviral agent; Biosynthesis; Fattiviracin; Streptomyces microflavus; Sugar conversion

Indexed keywords

ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CARBOHYDRATE; CERULENIN; FATTIVIRACIN FV 8; FATTIVIRACIN FV-8; GLUCOSE; GLYCOLIPID;

ARTICLE; BIOSYNTHESIS; CARBOHYDRATE METABOLISM; CELL FREE SYSTEM; CHEMISTRY; CULTURE MEDIUM; METABOLISM; STREPTOMYCES;

ANTIBIOTICS, ANTIFUNGAL; ANTIVIRAL AGENTS; CARBOHYDRATE METABOLISM; CARBOHYDRATES; CELL-FREE SYSTEM; CERULENIN; CULTURE MEDIA; GLUCOSE; GLYCOLIPIDS; STREPTOMYCES;

EID: 0035319790     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.65.861     Document Type: Article

References (11)

1. Uyeda, M., Yokomizo, K., Miyamoto, Y., and Habib, E., Fattiviracin A1, a novel antiherpetic agent produced by Streptomyces microflavus strain No. 2445. I. Taxonomy, fermentation, isolation, physicochemical properties and structure elucidation. J. Antibiotics, 51, 823-828 (1998).
2. Yokomizo, K., Miyamoto, Y., Nagao, K., Kumagae, E., Habib, E., Suzuki, K., Harada, S., and Uyeda, M., Fattiviracin A1, a novel antiviral agent produced by Streptomyces microflavus strain No. 2445. II. Biological properties. J. Antibiotics, 51, 1035-1039 (1998).
3. Habib, E., Yokomizo, K., Murata, K., and Uyeda, M., Structures of fattiviracin family, antiviral antibiotics. J. Antibiotics, 53, 1420-1423 (2000).
4. Schinazi, R. F., Peters, J., Williams, C. C., Chance, D., and Nahmias, A. J., Effect of combinations of acyclovir with vidarabine or its 5́-monophosphate on herpes simplex viruses in cell culture and in mice. Antimicrob. Agent. Chemother., 22, 499-507 (1982).
5. Hancock, D., and Synovec, R., Microbore liquid chromatography and refractive index gradient detection of low-nanogram and low-ppm quantities of carbohydrates. J. Chromatography, 464, 83-91 (1989).
6. Walfridsson, M., Hallborn, J., Penttila, M., Keranen, S., and Hahn-Hagerdal, B., Xylose-Metabolizing Saccharomyces cerevisiae strains over-expressing the TKL1 and TAL1 genes encoding the pentose phosphate pathway enzymes transketolase and transaldolase. Appl. Environ. Microbiol., 61, 4184-4190 (1995).
7. O'Hagan, D., Biosynthesis of fatty acid and polyketide metabolites. Natural Product Reports, 9, 447-479 (1992).
8. Omura, S., The antibiotics cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriological Reviews, 40, 681-697 (1976).
9. Takeshima, H., Kitao, C., and Omura, S., Inhibition of the biosynthesis of leucomycin, a macrolide antibiotic, by cerulenin. J. Biochem., 81, 1127-1132 (1977).
10. Omura, S., Kitao, C., Hamada, H., and Ikeda, H., Bioconversion and biosynthesis of 16-membered macrolide antibiotics. X. Final steps in the biosynthesis of spiramycin, using an enzyme inhibitor: cerulenin. Chem. Pharm. Bull., 27, 176-182 (1979).
11. Omura, S., Kitao, C., Miyazawa, J., Imai, H., and Takeshima, H., Bioconversion and biosynthesis of 16-membered macrolide antibiotic, tylosin, using an enzyme inhibitor : cerulenin. J. Antibiotics, 31, 254-256 (1978).